SCHEMBL6171765

SCHEMBL6171765

CC1(Cc2ccnc(NC(=O)Oc3ccccc3)c2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 6/20 0.41
EPHX2 P34913 1/20 0.37
PTGS2 P35354 1/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
TSHR P16473 1/20 0.35
SLC5A1 P13866 4/20 0.34
KCNH2 Q12809 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN9A Q15858 1/20 0.34
AR P10275 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 1/20 0.34
FLT1 P17948 2/20 0.34
KDR P35968 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175032 0.89 MAPK1 (0.43) IGF1REPHX2PTGS2KMT2AMEN1
SCHEMBL6173728 0.89 MEN1 (0.47) IGF1REPHX2PTGS2KMT2AMEN1
SCHEMBL6172735 0.89 IGF1R (0.42) IGF1REPHX2SLC5A1ARCYP3A4
SCHEMBL6173886 0.88 IGF1R (0.40) IGF1REPHX2PTGS2KMT2ATSHR
SCHEMBL6173624 0.88 IGF1R (0.42) IGF1RARCYP3A4GAACYP2C9
SCHEMBL6174016 0.87 IGF1R (0.41) IGF1RTSHRSLC5A1ARCYP3A4
SCHEMBL6173853 0.87 IGF1R (0.37) IGF1REPHX2PTGS2KMT2AKCNH2
SCHEMBL6177003 0.85 TDP1 (0.42) IGF1RKMT2AGAAKDR
SCHEMBL6177217 0.85 TLR7 (0.39) IGF1RCYP3A4GAACYP2C9CYP2C19
SCHEMBL6172079 0.84 IGF1R (0.47) IGF1RKMT2ATSHRARCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed